(Total Views: 79)
Posted On: 10/06/2020 8:05:51 AM
Post# of 85462

$AFMD News Article - Affimed Announces Dosing of First Patient in Phase 1 Clinical Trial of Cord Blood-derived Natural Killer Cells in Combination with the Innate Cell Engager AFM13 https://marketwirenews.com/news-releases/affi...54662.html


My Twitter: WhyteStocks